Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting symbols : Eq save search
Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
Published: 2023-11-13 (Crawled : 17:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: 0.08%
H: 6.43%
C: 0.81%
positive meeting study
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
Published: 2023-11-06 (Crawled : 14:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: -4.0%
H: 8.29%
C: 3.13%
meeting study
Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology
Published: 2023-10-19 (Crawled : 13:30) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: 1.28%
H: 0.0%
C: -2.93%
presentation
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
Published: 2023-05-15 (Crawled : 14:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: 3.09%
H: 25.0%
C: 13.33%
association presentation meeting
Equillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow Transplantation
Published: 2023-04-24 (Crawled : 13:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: 5.69%
H: 7.18%
C: -5.74%
presentation blood meeting
Equillium Announces Abstract Accepted for Oral Presentation at the Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
Published: 2023-01-13 (Crawled : 17:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: 4.24%
H: 0.0%
C: -10.57%
cibmtr presentation therapy
Equillium Announces Three Poster Presentations at the Annual Meeting of The American Association of Immunologists
Published: 2022-05-09 (Crawled : 13:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -5.93%
Equillium Announces Three Poster Presentations at the Transplantation & Cellular Meetings of the ASTCT and CIBMTR
Published: 2022-04-25 (Crawled : 13:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: -0.67%
H: 3.2%
C: -2.36%
cibmtr
Equillium Presents Clinical Data from EQUALISE Phase 1b Study in Lupus Patients at the American Society of Nephrology Annual Meeting
Published: 2021-11-05 (Crawled : 13:15) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: -1.81%
H: 3.54%
C: 0.15%
phase 1 phase 1b lupus phase 2b
Equillium Presents Interim Safety Data from First Cohort of Asthma Patients in Phase 1b EQUIP Study at the American College of Allergy, Asthma & Immunology Meeting
Published: 2021-11-05 (Crawled : 13:15) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: -1.81%
H: 3.54%
C: 0.15%
phase 1 immunology phase 1b phase 2b
Equillium Announces Interim Safety Data and Reduction in Proteinuria for Lupus Patients Treated with Itolizumab in the EQUALISE Study Presented at the ACR Annual Meeting
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: 1.44%
H: 4.11%
C: 2.37%
lupus
Equillium Announces Two Abstracts Accepted for Presentation at the Upcoming Virtual 2021 American Society of Nephrology Annual Meeting
Published: 2021-10-18 (Crawled : 13:00) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: -2.36%
H: 1.9%
C: -1.38%
presentation
Equillium Announces Positive Data for Itolizumab in Acute Graft-Versus-Host Disease in Two Presentations at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation
Published: 2021-03-15 (Crawled : 12:00) - globenewswire.com
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: 3.03%
H: 6.75%
C: 1.84%
presentation disease blood positive
Equillium Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease at the 2021 Transplantation and Cellular Therapy Meetings Digital Experience
Published: 2021-02-12 (Crawled : 20:03) - globenewswire.com
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
| Email alert
Add to watchlist
disease treatment positive therapy
Equillium Announces Acceptance of Late-Breaking Abstract for Oral Presentation of Interim Data from EQUATE Study in acute GVHD at the 2021 TCT Meetings Digital Experience
Published: 2021-01-22 (Crawled : 13:01) - globenewswire.com
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: 1.75%
H: 4.81%
C: 3.26%
Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell Function at the 2020 American Society of Hematology Annual Meeting and Exposition
Published: 2020-12-07 (Crawled : 13:01) - globenewswire.com
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: 0.0%
H: 0.41%
C: -3.67%
t-cell
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.